Market Research Trends

The  Gastro-retentive Drug Delivery Systems Market  revenues were estimated at US$ 13.3 Billion in 2022 and is anticipated to grow at a CAGR of 10.1% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 24.8 Billion. Large drug firms’ investments to enhance gastro-retentive drug-delivery systems, along with the reduction in required doses due to enhanced bioavailability and an increase in the requirements for medications, have helped accelerate the market growth. The well-established efficacy of gastro-retentive drug delivery systems in treating a variety of stomach disorders such as peptic ulcer and gastric ulcer, as well as a growth in the incidence of H. Pylori infection, which can cause gastritis and gastric cancer, impart a significant impact on the market. Gastro-retentive drug distribution technology has proven to be a useful way of regulating the administration of a wide range of med...

The  Gastro-retentive Drug Delivery Systems Market  revenues were estimated at US$ 13.3 Billion in 2022 and is anticipated to grow at a CAGR of 10.1% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 24.8 Billion. Large drug companies' expenditures in improving gastro-retentive drug-delivery systems, as well as a reduction in required doses due to improved bioavailability and an increase in medicine requirements, have aided market expansion. The market is influenced by the well-established efficiency of gastro-retentive drug delivery systems in treating a variety of stomach ailments such as peptic ulcer and gastric ulcer, as well as an increase in the incidence of H. Pylori infection, which can cause gastritis and gastric cancer. Gastro-retentive drug distribution technology has proven to be an effective method of controlling the delivery of a wide range of pharmaceutical compounds wh...